- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Amyotrophic lateral sclerosis (ALS)
- Meeting Date: November 2023
- Public Summary Document (PSD) November 2023 PBAC Meeting - (PDF 1.7MB)
- Public Summary Document (PSD) November 2023 PBAC Meeting - (Word 1.4MB)
Edaravone – November 2023
Edaravone: Solution concentrate for injection 30 mg in 20 mL; Radicava®
Last updated
15 March 2024